Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.39
+0.04 (0.63%)
At close: Dec 5, 2025, 4:00 PM EST
6.27
-0.12 (-1.88%)
After-hours: Dec 5, 2025, 5:58 PM EST
Sagimet Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -57.67 | -45.57 | -27.88 | -30.5 | -24.44 | -11.37 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.02 | |
| Loss (Gain) From Sale of Investments | -0.75 | -1.25 | -0.04 | -0.21 | - | - | |
| Stock-Based Compensation | 6.29 | 5.29 | 4.99 | 1.88 | 1.9 | 0.78 | |
| Other Operating Activities | 0.38 | 0.15 | 0.14 | 0.13 | 0.88 | 0.12 | |
| Change in Accounts Payable | 5.35 | -0.91 | 0.12 | 2.92 | 0.56 | -0.36 | |
| Change in Other Net Operating Assets | 1.56 | -0.14 | -1.1 | 1.3 | -0.62 | 0.44 | |
| Operating Cash Flow | -44.84 | -42.44 | -23.77 | -24.49 | -21.71 | -10.42 | |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.02 | |
| Investment in Securities | 0.05 | -61.68 | 12.58 | -32.01 | - | - | |
| Investing Cash Flow | 0.05 | -61.68 | 12.58 | -32.01 | - | 0.02 | |
| Issuance of Common Stock | 0.28 | 105.86 | 89.69 | 0.01 | 0.19 | - | |
| Other Financing Activities | - | -1.05 | -3.52 | -0.09 | -1.25 | - | |
| Financing Cash Flow | 0.28 | 104.82 | 86.17 | -0.07 | 9.74 | 68.89 | |
| Net Cash Flow | -44.52 | 0.7 | 74.98 | -56.57 | -11.97 | 58.49 | |
| Levered Free Cash Flow | -26.94 | -29.73 | -15.08 | -13.21 | -14.27 | -5.96 | |
| Unlevered Free Cash Flow | -26.94 | -29.73 | -15.08 | -13.21 | -14.27 | -5.96 | |
| Change in Working Capital | 6.9 | -1.05 | -0.98 | 4.21 | -0.06 | 0.08 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.